Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controlling the Polarity of Ag:PSS Polyelectrolyte Interfacial Layers in Organic Solar Cells.

ACS omega·2026
Same author

A human liver organoid platform for hepatotoxicity assessment: evaluation using reference compounds.

Frontiers in toxicology·2026
Same author

Tinnitus and tinnitus disorder: Genetic, neurobiological, and clinical differentiation.

iScience·2026
Same author

Sound hypersensitivity phenotypes and sound hypersensitivity disorder.

Neuroscience and biobehavioral reviews·2026
Same author

Correction: Comprehensive performance assessment of the BMIA-12 a system for bone marrow cell quantification in normal and hematological malignancy samples.

Scientific reports·2026
Same author

Usability Testing of a Hair Apposition Device for Scalp Laceration: A Manikin Simulation Study.

Emergency medicine international·2026

Related Experiment Video

Updated: Jun 15, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

Geranylgeranylacetone ameliorates acute cochlear damage caused by 3-nitropropionic acid.

Young Ho Kim1, Jae-Jin Song, Young Chul Kim

  • 1Department of Otolaryngology, Seoul National University, Boramae Medical Center, Seoul, South Korea. yhkiment@gmail.com

Neurotoxicology
|March 16, 2010
PubMed
Summary

Geranylgeranylacetone (GGA) protects against 3-nitropropionic acid (3-NP)-induced hearing loss by preserving cochlear mitochondria. GGA pretreatment significantly reduced hearing threshold shifts and protected vital cochlear cells from 3-NP damage.

More Related Videos

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
09:06

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Published on: January 9, 2019

Related Experiment Videos

Last Updated: Jun 15, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
09:06

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Published on: January 9, 2019

Area of Science:

  • Oto-toxicology
  • Mitochondrial dysfunction
  • Neuroprotection

Background:

  • 3-Nitropropionic acid (3-NP) is a mitochondrial toxin that causes hearing loss.
  • Geranylgeranylacetone (GGA) is known for its protective effects against various cellular injuries.
  • The cochlea's susceptibility to mitochondrial damage necessitates investigation into protective agents.

Purpose of the Study:

  • To evaluate the protective efficacy of Geranylgeranylacetone (GGA) against acute 3-nitropropionic acid (3-NP)-induced cochlear mitochondrial damage.
  • To assess the impact of GGA on auditory function and cochlear histology following 3-NP exposure.

Main Methods:

  • Female Hartley guinea pigs were administered 3-NP with or without GGA pretreatment.
  • Auditory brainstem response (ABR) was recorded to assess hearing thresholds.
  • Cochlear tissues were analyzed using hematoxylin/eosin staining and HSP70 immunohistochemistry.

Main Results:

  • 3-NP exposure significantly elevated ABR thresholds, indicating profound hearing loss.
  • GGA pretreatment markedly reduced the hearing threshold shift caused by 3-NP.
  • Histological analysis revealed preservation of cochlear cells (fibrocytes, hair cells, ganglion cells) in GGA-pretreated animals compared to 3-NP alone group.

Conclusions:

  • Geranylgeranylacetone (GGA) demonstrates significant protective effects against 3-nitropropionic acid (3-NP)-induced ototoxicity.
  • GGA may safeguard cochlear mitochondria and cellular structures, thereby preventing hearing loss associated with mitochondrial dysfunction.